First Trust NYSE Arca Biotechnology Index Fund
243 hedge funds and large institutions have $717M invested in First Trust NYSE Arca Biotechnology Index Fund in 2023 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 51 increasing their positions, 91 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
1.42% less ownership
Funds ownership: 50.9% → 49.48% (-1.4%)
44% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 91
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
243
Holding in Top 10
2
Calls
$1.83M
Puts
$310K
Top Buyers
| 1 | +$7.63M | |
| 2 | +$5.42M | |
| 3 | +$4.91M | |
| 4 |
PFS
Prospera Financial Services
Dallas,
Texas
|
+$4.56M |
| 5 |
Jane Street
New York
|
+$4.32M |
Top Sellers
| 1 | -$16.7M | |
| 2 | -$9.45M | |
| 3 | -$9.01M | |
| 4 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
-$5.82M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$4.71M |